Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Juno_Therapeutics> ?p ?o }
Showing triples 1 to 74 of
74
with 100 triples per page.
- Juno_Therapeutics abstract "Juno Therapeutics is a biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. The company was launched with an initial investment of $120 million, with a remit to develop a pipeline of cancer immunotherapy drugs. The company raised $300 million through private funding and a further $265 million through their IPO.".
- Juno_Therapeutics foundingYear "2013".
- Juno_Therapeutics industry Biotechnology.
- Juno_Therapeutics keyPerson Chief_Medical_Officer.
- Juno_Therapeutics keyPerson Chief_executive_officer.
- Juno_Therapeutics keyPerson Chief_financial_officer.
- Juno_Therapeutics keyPerson Chief_science_officer.
- Juno_Therapeutics location Seattle.
- Juno_Therapeutics type Public_company.
- Juno_Therapeutics wikiPageExternalLink junotherapeutics.com.
- Juno_Therapeutics wikiPageID "47030169".
- Juno_Therapeutics wikiPageLength "6792".
- Juno_Therapeutics wikiPageOutDegree "25".
- Juno_Therapeutics wikiPageRevisionID "705839256".
- Juno_Therapeutics wikiPageWikiLink AbVitro.
- Juno_Therapeutics wikiPageWikiLink Acute_myeloid_leukemia.
- Juno_Therapeutics wikiPageWikiLink AstraZeneca.
- Juno_Therapeutics wikiPageWikiLink B-cell_chronic_lymphocytic_leukemia.
- Juno_Therapeutics wikiPageWikiLink Biotechnology.
- Juno_Therapeutics wikiPageWikiLink Category:Biopharmaceutical_companies.
- Juno_Therapeutics wikiPageWikiLink Category:Companies_listed_on_NASDAQ.
- Juno_Therapeutics wikiPageWikiLink Celgene.
- Juno_Therapeutics wikiPageWikiLink Chief_Medical_Officer.
- Juno_Therapeutics wikiPageWikiLink Chief_executive_officer.
- Juno_Therapeutics wikiPageWikiLink Chief_financial_officer.
- Juno_Therapeutics wikiPageWikiLink Chief_science_officer.
- Juno_Therapeutics wikiPageWikiLink Editas_Medicine.
- Juno_Therapeutics wikiPageWikiLink Fred_Hutchinson_Cancer_Research_Center.
- Juno_Therapeutics wikiPageWikiLink Immunotherapy.
- Juno_Therapeutics wikiPageWikiLink Initial_public_offering.
- Juno_Therapeutics wikiPageWikiLink MedImmune.
- Juno_Therapeutics wikiPageWikiLink Memorial_Sloan_Kettering_Cancer_Center.
- Juno_Therapeutics wikiPageWikiLink Merck_Group.
- Juno_Therapeutics wikiPageWikiLink Neuroblastoma.
- Juno_Therapeutics wikiPageWikiLink Non-Hodgkin_lymphoma.
- Juno_Therapeutics wikiPageWikiLink Pfizer.
- Juno_Therapeutics wikiPageWikiLink Public_company.
- Juno_Therapeutics wikiPageWikiLink Seattle.
- Juno_Therapeutics wikiPageWikiLink Seattle_Childrens_Research_Institute.
- Juno_Therapeutics wikiPageWikiLinkText "Juno Therapeutics".
- Juno_Therapeutics wikiPageWikiLinkText "Juno".
- Juno_Therapeutics foundation "2013".
- Juno_Therapeutics industry Biotechnology.
- Juno_Therapeutics keyPeople "Hans Bishop".
- Juno_Therapeutics keyPeople "Hyam Levitsky, M.D.".
- Juno_Therapeutics keyPeople "Mark Gilbert, M.D.".
- Juno_Therapeutics keyPeople "Steve Harr, M.D.".
- Juno_Therapeutics location "Seattle, WA".
- Juno_Therapeutics logo "File:Juno Therapeutics logo.jpg".
- Juno_Therapeutics name "Juno Therapeutics Inc".
- Juno_Therapeutics type Public_company.
- Juno_Therapeutics wikiPageUsesTemplate Template:Infobox_company.
- Juno_Therapeutics wikiPageUsesTemplate Template:NASDAQ.
- Juno_Therapeutics wikiPageUsesTemplate Template:Reflist.
- Juno_Therapeutics wikiPageUsesTemplate Template:URL.
- Juno_Therapeutics subject Category:Biopharmaceutical_companies.
- Juno_Therapeutics subject Category:Companies_listed_on_NASDAQ.
- Juno_Therapeutics hypernym Company.
- Juno_Therapeutics type Agent.
- Juno_Therapeutics type Company.
- Juno_Therapeutics type Organisation.
- Juno_Therapeutics type Organization.
- Juno_Therapeutics type Agent.
- Juno_Therapeutics type SocialPerson.
- Juno_Therapeutics type Thing.
- Juno_Therapeutics type Q43229.
- Juno_Therapeutics comment "Juno Therapeutics is a biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. The company was launched with an initial investment of $120 million, with a remit to develop a pipeline of cancer immunotherapy drugs. The company raised $300 million through private funding and a further $265 million through their IPO.".
- Juno_Therapeutics label "Juno Therapeutics".
- Juno_Therapeutics sameAs Q22121867.
- Juno_Therapeutics sameAs Q22121867.
- Juno_Therapeutics wasDerivedFrom Juno_Therapeutics?oldid=705839256.
- Juno_Therapeutics homepage junotherapeutics.com.
- Juno_Therapeutics isPrimaryTopicOf Juno_Therapeutics.
- Juno_Therapeutics name "Juno Therapeutics Inc".